Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Department of Family Medicine, Siaal Research Center for Family Medicine and Primary Care, The Haim Doron Division of Community Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel; and.
Am J Ther. 2024;31(4):e372-e381. doi: 10.1097/MJT.0000000000001749.
Public and medical interest in the use of cannabis has increased in Israel and the world over recent years.
The aim of the study was to assess the attitudes of medical students from the Faculty of Health Sciences of Ben-Gurion University of the Negev on the use of medical cannabis.
This is a cross-sectional study using a self-administered questionnaire completed by medical students from Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Attitudes and knowledge toward the use of medical cannabis were evaluated.
A total of 243 medical students participated in the study. Of these, 111 (46.1%) were from preclinical years. The mean age was 27.31 ± 3.07, and 138 (57.3%) were female students. Most students (N = 193, 79.4%) agreed to a great degree or to a very great degree that there was a role for cannabis for medical purposes. Most students thought that medical cannabis should be recommended for use by pain specialists (N = 231, 95.1%), by oncologists (N = 208, 85.6%), and by psychiatrists (N = 192, 79%). A little more than half of the participants (N = 127, 52.5%) would agree to be licensed, as future physicians, to prescribe medical cannabis. A logistic regression analysis found that the students strongly agreed with legalization of medical cannabis and students who strongly agreed that medical cannabis should be in the health basket predicted a very strong agreement about its use (OR = 2.623, P ≤ 0.002, and OR = 3.285, P ≤ 0.001, respectively).
Most medical students support the use of medical cannabis for medical purposes and are in favor of its legalization. As physicians of the future, it is important to assess the attitudes of medical students on medical cannabis.
近年来,无论是在以色列还是在全世界,公众和医学界对大麻使用的兴趣都有所增加。
本研究旨在评估内盖夫本古里安大学健康科学学院医学生对医用大麻使用的态度。
这是一项使用自我管理问卷的横断面研究,由以色列贝尔谢巴内盖夫本古里安大学的医学生完成。
评估了医学生对医用大麻使用的态度和知识。
共有 243 名医学生参与了研究。其中,111 名(46.1%)来自临床前阶段。平均年龄为 27.31±3.07 岁,其中 138 名(57.3%)为女学生。大多数学生(N=193,79.4%)非常同意或非常同意大麻在医疗上有一定作用。大多数学生认为医用大麻应由疼痛专家(N=231,95.1%)、肿瘤学家(N=208,85.6%)和精神科医生(N=192,79%)推荐使用。超过一半的参与者(N=127,52.5%)作为未来的医生,将同意获得许可开医用大麻处方。逻辑回归分析发现,学生强烈同意医用大麻合法化,并且强烈同意医用大麻应该纳入医疗保健篮子的学生,预测对其使用有非常强烈的同意(OR=2.623,P≤0.002,OR=3.285,P≤0.001)。
大多数医学生支持医用大麻用于医疗目的,并赞成其合法化。作为未来的医生,评估医学生对医用大麻的态度很重要。